HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 15 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
NCKAP1L
NCK associated protein 1 like
Chromosome 12 Β· 12q13.13-q13.2
NCBI Gene: 3071Ensembl: ENSG00000123338.14HGNC: HGNC:4862UniProt: P55160
29PubMed Papers
21Diseases
0Drugs
12Pathogenic Variants
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
GTPase activator activityprotein bindingprotein kinase activator activityprotein-containing complex bindingimmunodeficiency 72 with autoinflammationImmunodeficiencyimmunodeficiency diseaseimmune system disease
✦AI Summary

NCKAP1L (NCK associated protein 1 like) is a hematopoietic-specific regulator of actin cytoskeleton dynamics that serves as a core component of the WAVE regulatory complex (WRC), which mediates branched actin polymerization 1. In immune cells, NCKAP1L controls lymphocyte development, activation, and proliferation, as well as neutrophil migration and phagocytosis 2. Within the WAVE2 complex, NCKAP1L restrains excessive T-cell degranulation while enabling efficient T-lymphocyte and neutrophil migration 2. The protein also regulates mTORC2-dependent AKT phosphorylation, supporting T-cell proliferation and cytokine secretion 3. In humans, recessive NCKAP1L mutations cause immunodeficiency 72 with autoinflammation and lymphoproliferation, characterized by combined immunodeficiency, lymphoproliferation, hyperinflammation with hemophagocytic features, and impaired T-cell immune synapse formation 2. Beyond immune function, NCKAP1L regulates actin dynamics in other contexts: HNF3Ξ± promotes renal fibrosis following ischemia-reperfusion injury by upregulating NCKAP1L expression 4, and NCKAP1L expression associates with improved osteosarcoma prognosis through immune cell recruitment 5. Emerging evidence suggests NCKAP1L as a diagnostic biomarker in sepsis and potentially other inflammatory conditions 6.

Sources cited
1
NCKAP1L deficiency in humans causes immunodeficiency, lymphoproliferation, hyperinflammation, impaired T-cell activation and immune synapse formation
PMID: 32766723
2
NCKAP1L is required for T-cell degranulation control, efficient migration, and mTORC2-dependent AKT phosphorylation
PMID: 32647003
3
NCKAP1L encodes HEM1 protein component of WAVE regulatory complex controlling actin dynamics in immune responses
PMID: 35869404
4
HNF3Ξ± promotes renal fibrosis after ischemia-reperfusion injury by increasing NCKAP1L expression
PMID: 40091743
5
NCKAP1L expression is enriched in non-metastatic osteosarcoma and associates with better survival through immune cell recruitment
PMID: 38844271
6
NCKAP1L is a potential diagnostic biomarker and therapeutic target in sepsis
PMID: 41075755
Disease Associationsβ“˜21
immunodeficiency 72 with autoinflammationOpen Targets
0.71Strong
ImmunodeficiencyOpen Targets
0.37Weak
immunodeficiency diseaseOpen Targets
0.37Weak
immune system diseaseOpen Targets
0.37Weak
renal fibrosisOpen Targets
0.07Suggestive
Alymphoid cystic thymic dysgenesisOpen Targets
0.06Suggestive
immunodeficiency 19Open Targets
0.06Suggestive
immunodeficiency 15aOpen Targets
0.06Suggestive
combined immunodeficiency due to ZAP70 deficiencyOpen Targets
0.06Suggestive
X-Linked Combined Immunodeficiency DiseasesOpen Targets
0.06Suggestive
severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positiveOpen Targets
0.06Suggestive
combined immunodeficiency with skin granulomasOpen Targets
0.06Suggestive
common variable immunodeficiencyOpen Targets
0.06Suggestive
T-B+ severe combined immunodeficiency due to JAK3 deficiencyOpen Targets
0.06Suggestive
Familial hemophagocytic lymphohistiocytosisOpen Targets
0.06Suggestive
isolated agammaglobulinemiaOpen Targets
0.06Suggestive
Wiskott-Aldrich syndromeOpen Targets
0.06Suggestive
severe combined immunodeficiency due to LAT deficiencyOpen Targets
0.06Suggestive
autoimmune diseaseOpen Targets
0.06Suggestive
activated PI3K-delta syndromeOpen Targets
0.06Suggestive
Immunodeficiency 72 with autoinflammation and lymphoproliferationUniProt
Pathogenic Variants12
NM_005337.5(NCKAP1L):c.1076C>T (p.Pro359Leu)Pathogenic
Immunodeficiency 72 with autoinflammation|not provided
β˜…β˜…β˜†β˜†2024β†’ Residue 359
NM_005337.5(NCKAP1L):c.1111A>G (p.Met371Val)Pathogenic
Immunodeficiency 72 with autoinflammation
β˜…β˜…β˜†β˜†2021β†’ Residue 371
NM_005337.5(NCKAP1L):c.1111A>C (p.Met371Leu)Likely pathogenic
Immunodeficiency 72 with autoinflammation
β˜…β˜†β˜†β˜†2024β†’ Residue 371
NM_005337.5(NCKAP1L):c.784+2T>GLikely pathogenic
not provided
β˜…β˜†β˜†β˜†2022
NM_005337.5(NCKAP1L):c.1555G>C (p.Val519Leu)Likely pathogenic
Immunodeficiency 72 with autoinflammation
β˜…β˜†β˜†β˜†2021β†’ Residue 519
NM_005337.5(NCKAP1L):c.773G>T (p.Arg258Leu)Likely pathogenic
Immunodeficiency 72 with autoinflammation
β˜…β˜†β˜†β˜†2021β†’ Residue 258
NM_005337.5(NCKAP1L):c.2T>C (p.Met1Thr)Likely pathogenic
Immunodeficiency 72 with autoinflammation
β˜…β˜†β˜†β˜†β†’ Residue 1
NM_005337.5(NCKAP1L):c.3346G>A (p.Ala1116Thr)Likely pathogenic
Immunodeficiency 72 with autoinflammation
β˜†β˜†β˜†β˜†2025β†’ Residue 1116
NM_005337.5(NCKAP1L):c.1492G>A (p.Val498Met)Likely pathogenic
Immunodeficiency 72 with autoinflammation
β˜†β˜†β˜†β˜†2025β†’ Residue 498
NM_005337.5(NCKAP1L):c.385C>T (p.Arg129Trp)Pathogenic
Immunodeficiency 72 with autoinflammation
β˜†β˜†β˜†β˜†2023β†’ Residue 129
NM_005337.5(NCKAP1L):c.421G>T (p.Val141Phe)Pathogenic
Immunodeficiency 72 with autoinflammation
β˜†β˜†β˜†β˜†2023β†’ Residue 141
NM_005337.5(NCKAP1L):c.2862+1G>APathogenic
Immunodeficiency 72 with autoinflammation
β˜†β˜†β˜†β˜†2023
View on ClinVar β†—
Related Genes
ARPC1BProtein interaction100%ACTR2Protein interaction100%WIPF1Protein interaction100%ARPC2Protein interaction100%ARPC3Protein interaction100%ARPC5Protein interaction99%
Tissue Expression6 tissues
Bone Marrow
100%
Lung
52%
Brain
6%
Liver
6%
Heart
5%
Ovary
3%
Gene Interaction Network
Click a node to explore
NCKAP1LARPC1BACTR2WIPF1ARPC2ARPC3ARPC5
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted Β· UniProt P55160
View on AlphaFold β†—
Constraintβ“˜
LOEUFβ“˜
0.46Moderately Constrained
pLIβ“˜
1.00Intolerant
Observed/Expected LoF0.36 [0.28–0.46]
RankingsWhere NCKAP1L stands among ~20K protein-coding genes
  • #12,185of 20,598
    Most Researched29
  • #2,711of 5,498
    Most Pathogenic Variants12
  • #2,597of 17,882
    Most Constrained (LOEUF)0.46 Β· top quartile
Genes detectedNCKAP1L
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
HNF3Ξ± Targets Nckap1l and Promotes Renal Fibrosis Following Ischemia-Reperfusion Injury.
PMID: 40091743
Adv Sci (Weinh) Β· 2025
1.00
2
NCKAP1L defects lead to a novel syndrome combining immunodeficiency, lymphoproliferation, and hyperinflammation.
PMID: 32766723
J Exp Med Β· 2020
0.90
3
A proteome-wide association study identifies putative causal proteins for breast cancer risk.
PMID: 39468330
Br J Cancer Β· 2024
0.80
4
Ahnak and Nckap1l as potential diagnostic biomarkers and therapeutic targets in Landiolol-mediated sepsis treatment.
PMID: 41075755
Comput Biol Chem Β· 2026
0.70
5
HEM1 Actin Immunodysregulatory Disorder: Genotypes, Phenotypes, and Future Directions.
PMID: 35869404
J Clin Immunol Β· 2022
0.60